Jean Gariépy

6.6k total citations · 1 hit paper
114 papers, 5.2k citations indexed

About

Jean Gariépy is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jean Gariépy has authored 114 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 34 papers in Immunology and 28 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jean Gariépy's work include Monoclonal and Polyclonal Antibodies Research (21 papers), RNA Interference and Gene Delivery (20 papers) and Immunotherapy and Immune Responses (14 papers). Jean Gariépy is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (21 papers), RNA Interference and Gene Delivery (20 papers) and Immunotherapy and Immune Responses (14 papers). Jean Gariépy collaborates with scholars based in Canada, United States and United Kingdom. Jean Gariépy's co-authors include Gary K. Schoolnik, Gregory M.K. Poon, Robert S. Hodges, Robert B. Cairns, Roger D. Kornberg, David S. Goldfarb, Beverley D. Cairns, Holly J. Neckerman, Elias Georges and Victor Ling and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jean Gariépy

113 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic peptides as nuclear localization signals

1986 395 citations Jean Gariépy, Gary K. Schoolnik et al. profile →

Peers

Countries citing papers authored by Jean Gariépy

Since Specialization

Citations

This map shows the geographic impact of Jean Gariépy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Gariépy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Gariépy more than expected).

Fields of papers citing papers by Jean Gariépy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Gariépy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Gariépy. The network helps show where Jean Gariépy may publish in the future.

Co-authorship network of co-authors of Jean Gariépy

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Gariépy. A scholar is included among the top collaborators of Jean Gariépy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Gariépy. Jean Gariépy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Emerging insights into ethnic-specific TP53 germline variants 2023 ·JNCI Journal of the National Cancer Institute ·Nicholas W. Fischer, Yu‐Heng Vivian, Jean Gariépy	6
2	Coupling Chlorin e6 to the surface of Nanoscale Gas Vesicles strongly enhances their intracellular delivery and photodynamic killing of cancer cells 2020 ·Scientific Reports ·(unknown), Jean Gariépy	12
3	The carcinoembryonic antigen IgV‐like N domain plays a critical role in the implantation of metastatic tumor cells 2013 ·Molecular Oncology ·Aws Abdul‐Wahid, Eric H.‐B. Huang, Marzena Cydzik, Eleonora Bolewska‐Pedyczak, Jean Gariépy	13
4	Tumor Antigen Epitopes Interpreted by the Immune System as Self or Abnormal-Self Differentially Affect Cancer Vaccine Responses 2010 ·Cancer Research ·Sean O. Ryan, Michael S. Turner, Jean Gariépy, Olivera J. Finn	43
5	Vaccine against MUC1 Antigen Expressed in Inflammatory Bowel Disease and Cancer Lessens Colonic Inflammation and Prevents Progression to Colitis-Associated Colon Cancer 2010 ·Cancer Prevention Research ·Pamela Beatty, Sowmya Narayanan, Jean Gariépy, Sarangarajan Ranganathan, Olivera J. Finn	62
6	Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals 2010 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), (unknown), Jean Gariépy	73
7	The Catalytic Subunit of Shiga-like Toxin 1 Interacts with Ribosomal Stalk Proteins and is Inhibited by Their Conserved C-Terminal Domain 2008 ·Journal of Molecular Biology ·Andrew J. McCluskey, Gregory M.K. Poon, Eleonora Bolewska‐Pedyczak, Tharan Srikumar, (unknown), Brian Raught, Jean Gariépy	65
8	Novel strategy for targeted photodynamic therapy of breast cancer using a chlorin e6 conjugated-aptamer 2007 ·Molecular Cancer Therapeutics ·C. S. M. Ferreira, Stuart K. Bisland, Jean Gariépy	1
9	Tandem Dimerization of the Human p53 Tetramerization Domain Stabilizes a Primary Dimer Intermediate and Dramatically Enhances its Oligomeric Stability 2006 ·Journal of Molecular Biology ·Gregory M.K. Poon, Richard D. Brokx, (unknown), Jean Gariépy	24
10	The importance of valency in enhancing the import and cell routing potential of protein transduction domain-containing molecules 2005 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), Gregory M.K. Poon, Jean Gariépy	41
11	A Role for the Protease-sensitive Loop Region of Shiga-like Toxin 1 in the Retrotranslocation of Its A1 Domain from the Endoplasmic Reticulum Lumen 2005 ·Journal of Biological Chemistry ·Paul LaPointe, Xin Wei, Jean Gariépy	48
12	Peptide- and Polymer-Based Gene Delivery Vehicles 2004 ·Humana Press eBooks ·Richard D. Brokx, Jean Gariépy	11
13	Fusion of the C _H 1 Domain of IgG ₁ to Epidermal Growth Factor (EGF) Prolongs its Retention in the Blood but Does Not Increase Tumor Uptake 2002 ·Cancer Biotherapy and Radiopharmaceuticals ·Judy Wang, Raymond M. Reilly, Paul Chen, (unknown), Mark R. Bray, Jean Gariépy, Conrad Chan, Jasbir Sandhu	3
14	In Vivo Generation of Cytotoxic T Cells from Epitopes Displayed on Peptide-Based Delivery Vehicles 2002 ·The Journal of Immunology ·Kim S. Kawamura, Ruey‐Chyi Su, Linh T. Nguyen, Alisha R. Elford, Pamela S. Ohashi, Jean Gariépy	7
15	Probing the surface of eukaryotic cells using combinatorial toxin libraries 2001 ·Current Biology ·Mark R. Bray, Stuart K. Bisland, (unknown), (unknown), Jean Gariépy	5
16	Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical. 1998 ·PubMed ·Raymond M. Reilly, Jean Gariépy	23
17	The 80L5C4 epitope overlaps with the homophilic binding site of the cell adhesion molecule gp80 of Dictyostelium 1992 ·Biochemistry and Cell Biology ·Xiang‐Fu Wu, Rajender K. Kamboj, Jean Gariépy, Chi‐Hung Siu	3
18	Rapid synthesis and introduction of a protected EDTA-like group during the solid-phase assembly of peptides 1991 ·Bioconjugate Chemistry ·Ravindra Arya, Jean Gariépy	14
19	Dictyostelium myosin-II heavy-chain kinase A is activated by autophosphorylation: studies with Dictyostelium myosin-II and synthetic peptides 1990 ·Biochemistry ·Quintus G. Medley, Jean Gariépy, Graham P. Côté	27
20	A common antigenic determinant found in two functionally unrelated toxins. 1984 ·The Journal of Experimental Medicine ·Jean Gariépy, P O’Hanley, Scott A. Waldman, Ferid Murad, Gary K. Schoolnik	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact